Transvenous lead extraction versus surgical lead extraction or conservative treatment for cardiac implantable electronic device infections: Propensity score‐weighted analyses of a nationwide claim‐based database
Pacing and Clinical Electrophysiology · 2023-08 · 46 (8) · 833-839
DOI: 10.1111/pace.14789 ↗At a glance
Journal article in Pacing and Clinical Electrophysiology, published online on 2023-07-23. Written by Mitsuru Wada and 18 co-authors. Institution: Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan. Major MEDLINE topics: Defibrillators, Implantable, Pacemaker, Artificial, Heart Diseases. Cited 9 times so far (Crossref); 13 references. Funded by: EP Cruise, Inc..
Abstract (original language)
Introduction
Infection is one of the most important complications associated with cardiac implantable electronic device (CIED) therapy. The number of reports comparing the outcomes of transvenous lead extraction (TLE), surgical lead extraction, and conservative treatment for CIED infections using a real‐world database is limited. This study investigated the association between the treatment strategies for CIED infections and their outcomes.
Methods
We performed a retrospective analysis of 3605 patients with CIED infections admitted to 681 hospitals using a nationwide claim‐based database collected between April 2012 and March 2018.
Results
We divided the 3605 patients into TLE ( n = 938 [26%]), surgical lead extraction ( n = 182 [5.0%]), and conservative treatment ( n = 2485 [69%]) groups. TLE was performed more frequently in younger patients and at larger hospitals ( p for trend < .001 for both). The rate of TLE increased during the study period, whereas that of surgical lead extraction decreased ( p for trend < .001 for both). TLE was associated with lower in‐hospital mortality (vs. surgical lead extraction: odds ratio [OR], 0.20; 95% CI, 0.06–0.70; vs. conservative treatment: OR, 0.45; 95% CI: 0.22–0.94) and lower 30‐day readmission rates (vs. surgical lead extraction: OR, 0.18; 95% CI: 0.06–0.56; vs. conservative treatment: OR, 0.06; 95% CI, 0.03–0.13) in propensity score‐weighted analyses.
Conclusions
Only 26% of patients hospitalized for CIED infections received TLE. TLE was associated with significantly lower in‐hospital mortality and 30‐day recurrence rates than surgical lead extraction and conservative treatment, suggesting that TLE should be more widely recommended as a first‐line treatment for CIED infections.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
- Department of Advanced Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
- Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Japan.
- Open Innovation Center, National Cerebral and Cardiovascular Center, Suita, Japan.
ORCID profiles: Tsukasa Kamakura, Satoshi Nagase, Kengo Kusano
Funding
- EP Cruise, Inc.
Cite
APA
Wada, M., Inoue, Y. Y., Nakai, M., Sumita, Y., Tonegawa-Kuji, R., Miyazaki, Y., Wakamiya, A., Shimamoto, K., Ueda, N., Nakajima, K., Kamakura, T., Yamagata, K., Ishibashi, K., Miyamoto, K., Nagase, S., Aiba, T., Iwanaga, Y., Miyamoto, Y., & Kusano, K. (2023). Transvenous lead extraction versus surgical lead extraction or conservative treatment for cardiac implantable electronic device infections: Propensity score‐weighted analyses of a nationwide claim‐based database. Pacing and Clinical Electrophysiology, 46(8), 833-839. https://doi.org/10.1111/pace.14789
Vancouver
Wada M, Inoue YY, Nakai M, Sumita Y, Tonegawa-Kuji R, Miyazaki Y, et al. Transvenous lead extraction versus surgical lead extraction or conservative treatment for cardiac implantable electronic device infections: Propensity score‐weighted analyses of a nationwide claim‐based database. Pacing and Clinical Electrophysiology. 2023;46(8):833-839. doi:10.1111/pace.14789
BibTeX
@article{Wada2023,
author = {Wada, Mitsuru and Inoue, Yuko Y and Nakai, Michikazu and Sumita, Yoko and Tonegawa-Kuji, Reina and Miyazaki, Yuichiro and Wakamiya, Akinori and Shimamoto, Keiko and Ueda, Nobuhiko and Nakajima, Kenzaburo and Kamakura, Tsukasa and Yamagata, Kenichiro and Ishibashi, Kohei and Miyamoto, Koji and Nagase, Satoshi and Aiba, Takeshi and Iwanaga, Yoshitaka and Miyamoto, Yoshihiro and Kusano, Kengo},
title = {Transvenous lead extraction versus surgical lead extraction or conservative treatment for cardiac implantable electronic device infections: Propensity score‐weighted analyses of a nationwide claim‐based database},
journal = {Pacing and Clinical Electrophysiology},
year = {2023},
volume = {46},
number = {8},
pages = {833--839},
doi = {10.1111/pace.14789}
}
EUVIMED